A carregar...
Selection, identification, and characterization of SARS-CoV-2 monoclonal antibody resistant mutants
The use of monoclonal neutralizing antibodies (mNAbs) is being actively pursued as a viable intervention for the treatment of Severe Acute Respiratory Syndrome CoV-2 (SARS-CoV-2) infection and associated coronavirus disease 2019 (COVID-19). While highly potent mNAbs have great therapeutic potential,...
Na minha lista:
| Publicado no: | J Virol Methods |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier B.V.
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7837211/ https://ncbi.nlm.nih.gov/pubmed/33513380 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jviromet.2021.114084 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|